FibroBiologics to Present at the BIO International Convention 2024
FibroBiologics, Inc. (FBLG)
Company Research
Source: GlobeNewswire
HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O’Heeron, will present a corporate update on recent business and clinical developments at the 2024 BIO International Convention, June 3-6, 2024, in San Diego, California. The presentation will occur on Tuesday, June 4, 2024, at 11:45 a.m. PDT in Theater 3. "Since presenting at the BIO International Convention last year, FibroBiologics has made tremendous progress as a company. This will be the first year we present at the conference as a public company after a successful direct listing in January," said Pete O’Heeron. "We are thrilled to showcase our latest advancements and the potential of our fibroblast-based
Show less
Read more
Impact Snapshot
Event Time:
FBLG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FBLG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FBLG alerts
High impacting FibroBiologics, Inc. news events
Weekly update
A roundup of the hottest topics
FBLG
News
- FibroBiologics Announces 2024 Annual Meeting of StockholdersGlobeNewswire
- FibroBiologics Files 2024 First Quarter ReportGlobeNewswire
- FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids [Yahoo! Finance]Yahoo! Finance
- FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based SpheroidsGlobeNewswire
- FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent OfficeGlobeNewswire
FBLG
Sec Filings
- 5/15/24 - Form S-1/A
- 5/15/24 - Form S-8
- 5/14/24 - Form 10-Q
- FBLG's page on the SEC website